Economic Burden of Renal Cell Carcinoma: Part I - An Updated Review

Author： Shih Ya-Chen T.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.4, 2011-04, pp. : 315-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Burden of Renal Cell Carcinoma in the US: Part II - An Updated Analysis

By Shih Ya-Chen T.  

PharmacoEconomics, Vol. 29, Iss. 4, 2011-04 ,pp. : 331-341

Adis International

Access to resources Recommend Favorite

En Bloc Adrenalectomy as Part of Radical Nephrectomy for Renal Cell Carcinoma. Is it Justified?

By Adshead J.M.   Livni N.   Christmas T.J.  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 95-97

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report

By  

Current Drug Targets, Vol. 17, Iss. 15, 2016-12 ,pp. : 1755-1760

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review

By  

Current Drug Targets, Vol. 18, Iss. 10, 2017-07 ,pp. : 1204-1213

Bentham Science Publishers

Access to resources Recommend Favorite

Lapatinib and renal cell carcinoma

By Gross-Goupil Marine   Bernhard Jean-Christophe   Ravaud Alain  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 11, 2012-11 ,pp. : 1727-1732

Informa Healthcare

Access to resources Recommend Favorite